These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12669549)

  • 21. Immunity status against coxsackie viruses B in 25 patients with acute myocarditis.
    Băicuş A; Persu A; Popa MI; Băicuş C
    Roum Arch Microbiol Immunol; 2006; 65(3-4):109-12. PubMed ID: 18389726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
    Yue-Chun L; Li-Sha G; Jiang-Hua R; Peng-Lin Y; Jia-Feng L; Ji-Fei T; Peng C; Zhan-Qiu Y
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):92-8. PubMed ID: 18209574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic effect of yupingfeng san and shengmai yin on Coxsackie B viral myocarditis].
    Chen S; Chang P; Wang C
    Zhong Xi Yi Jie He Za Zhi; 1990 Jan; 10(1):20-1, 3. PubMed ID: 2161712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Index state of contact platelet activation in patients with acute viral myocarditis].
    Doroshenko BH; Saliuta MIu; Nazar PS; Kononiuk OA
    Lik Sprava; 2006 Dec; (8):45-7. PubMed ID: 17427424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
    Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
    J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical severity of viral myocarditis is not associated with a mutation of dystrophin gene cleavage sites.
    Lee M; Choi JO; Yun SH; Ju ES; Lee YJ; Kim JW; Lim BK; Jeon ES
    Int J Cardiol; 2015 Sep; 194():21-2. PubMed ID: 26011260
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
    Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
    J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The efficacy of taktivin in patients with viral myocarditis and dilated cardiomyopathy].
    Kipshidze NN; Dzhaparidze MM; Dzidziguri LM; Rachvelishvili NB; Dateshidze MN; Demetrashvili MF
    Ter Arkh; 1990; 62(9):116-8. PubMed ID: 2177920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of Coxsackie B viruses in the etiology of dilated cardiomyopathy].
    Novikov IuI; Stulova MA; Lavrova IK
    Ter Arkh; 1989; 61(11):97-102. PubMed ID: 2561232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Possible relationship between acute viral myocarditis and dilated cardiomyopathy].
    Jiang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Feb; 20(1):4-6, 69. PubMed ID: 1327706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indices of the interferon system in patients with viral myocarditis and dilated cardiomyopathy].
    Kipshidze NN; Chumburidze VB; Bakhutashvili VI; Korsantiia BM; Demetrashvili MF
    Ter Arkh; 1988; 60(11):43-6. PubMed ID: 2853455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.
    Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Various aspects of the pathogenesis, clinical course and treatment of myocarditis. II].
    Bilińska ZT
    Kardiol Pol; 1987; 30(7):452-8. PubMed ID: 2824915
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of Coxsackie group B viral infection in nonrheumatic myocarditis and recurrent rheumocarditis].
    Nunaev VL; Novikov IuI; Stulova MA; Lavrova IK
    Vopr Revm; 1979; (4):24-8. PubMed ID: 230637
    [No Abstract]   [Full Text] [Related]  

  • 36. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
    Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
    Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myocarditis associated with coxsackievirus B4 mimicking influenza myocarditis: electron microscopy detection of causal virus of myocarditis.
    Ikeda T; Saito T; Takagi G; Sato S; Takano H; Hosokawa Y; Hayashi M; Asai K; Yasutake M; Mizuno K
    Circulation; 2013 Dec; 128(25):2811-2. PubMed ID: 24366591
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute viral myocarditis: role of immunosuppression: a prospective randomised study.
    Aziz KU; Patel N; Sadullah T; Tasneem H; Thawerani H; Talpur S
    Cardiol Young; 2010 Oct; 20(5):509-15. PubMed ID: 20584348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ventricular extrasystole as manifestation of viral myocarditis and myopericarditis in young patients].
    Stulova MA; Konstantinova EV
    Ter Arkh; 2007; 79(12):28-34. PubMed ID: 18220027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent coxsackie B viral myocarditis leading to progressive impairment of left ventricular function over 8 years.
    Karavidas A; Lazaros G; Noutsias M; Matzaraki V; Danias PG; Pyrgakis V; Voudris V; Adamopoulos S
    Int J Cardiol; 2011 Sep; 151(2):e65-7. PubMed ID: 21889035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.